Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Recently, research into the development of new targeted therapies has focused on specific genetic alterations to create advanced, more personalized treatment. One of the target genes, fibroblast growth factor receptor‐1 (FGFR1), has been reported to be amplified in estrogen receptor (ER)‐positive su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomiguchi, Mai, Yamamoto, Yutaka, Yamamoto‐Ibusuki, Mutsuko, Goto‐Yamaguchi, Lisa, Fujiki, Yoshitaka, Fujiwara, Saori, Sueta, Aiko, Hayashi, Mitsuhiro, Takeshita, Takashi, Inao, Touko, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832856/
https://www.ncbi.nlm.nih.gov/pubmed/26801869
http://dx.doi.org/10.1111/cas.12897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832856/
https://www.ncbi.nlm.nih.gov/pubmed/26801869
http://dx.doi.org/10.1111/cas.12897

Ejemplares similares